SURMOUNT-4 will address the question of weight regain after stopping the drug: patients who took tirzepatide for 6 months, will be assessed for sustained weight loss one year later (NCT04660643)
Semaglutide vs tirzepatide is not a simple better-or-worse comparison
To illustrate, because of rising costs, five more Medicaid state agencies, including Californias MediCal, ended coverage of weight loss drugs per the first of this month
For others, no, and the injection is still the better recommendation
FIGURE 1 Currently, two main classes of GLP-1 RAs are available (Mller et al., 2019
Among adults ages 18 to 24, fewer than 14% say they are very satisfied